ISA Pharmaceuticals (Netherlands)

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Matthew M. Gubin, Xiuli Zhang, Heiko Schuster et al. · Nature · 2014 · 2K citations · Full text

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

Gemma G. Kenter, Marij J.P. Welters, A. Rob P.M. Valentijn et al. · New England Journal of Medicine · 2009 · 1.1K citations · Full text

Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer

Erminia Massarelli, William William, Faye M. Johnson et al. · JAMA Oncology · 2018 · 449 citations · Full text

The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation

Nick Barker · The EMBO Journal · 2001 · 448 citations · Full text

Chromatin, Cell Regulation, Chromatin Remodeling +11

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

Marij J.P. Welters, Gemma G. Kenter, Peggy J. de Vos van Steenwijk et al. · Proceedings of the National Academy of Sciences · 2010 · 236 citations · Full text